A. Dimitrios Colevas

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text

Medicine, Oncology, Metastasis +5

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Marshall R. Posner, Diáne Hershock, C. Blajman et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

Medicine, Oncology, Chemotherapy +8

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

David G. Pfister, Sharon Spencer, David J. Adelstein et al. · Journal of the National Comprehensive Cancer Network · 2020 · 1.4K citations

Medicine, Oncology, Otolaryngology +17

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.3K citations

Medicine, Oncology, Radiation Oncology +6

Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · Oral Oncology · 2018 · 800 citations · Full text

Medicine, Oncology, Metastasis +14